IMMUNE-MEDIATED DERMATITIS

This adverse event was reported 1008 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED DERMATITIS:

# Drug Count
0 NIVOLUMAB 390
1 IPILIMUMAB 304
2 CARBOPLATIN 234
3 PACLITAXEL 156
4 PEMETREXED DISODIUM 84
5 PEMETREXED 75
6 DURVALUMAB 64
7 CISPLATIN 60
8 TREMELIMUMAB 43
9 BEVACIZUMAB 38
See all common drugs associated with IMMUNE-MEDIATED DERMATITIS

IMMUNE-MEDIATED DERMATITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ENSITRELVIR 1 0.0556
1 MAGNESIUM OXIDE 400MG 1 0.0133
2 TREMELIMUMAB 43 0.0097
3 IPILIMUMAB 304 0.0069
4 NIVOLUMAB 390 0.0040
5 NIVOLUMAB AND RELATLIMAB-RMBW 2 0.0039
6 NALDEMEDINE 5 0.0030
7 DURVALUMAB 64 0.0030
8 CLEMASTINE FUMARATE 4 0.0029
9 BELINOSTAT 1 0.0028
See all drugs enriched for association with IMMUNE-MEDIATED DERMATITIS